Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Gambaro

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Bulletin De L'Academie Nationale De Medecine|October 26, 2005
[Embryonic stem cells and epidermal commitment]Daniel Aberdam, Karen Gambaro, Robert Barthel, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2007
Key role of p63 in BMP-4-induced epidermal commitment of embryonic stem cellsDaniel Aberdam, Karen Gambaro, Philippe Rostagno, et al.
Plos One|October 18, 2008
DeltaNp63 is essential for epidermal commitment of embryonic stem cellsAlain Medawar, Thierry Virolle, Philippe Rostagno, et al.
Comptes Rendus Biologies|July 17, 2007
Embryonic stem cells as a cellular model for neuroectodermal commitment and skin formationDaniel Aberdam, Karen Gambaro, Alain Medawar, et al.
Surgery|August 6, 2019
Multiplexed real-time polymerase chain reaction cell-free DNA assay as a potential method to monitor stage IV colorectal cancerSudhir Sinha, Hiromi Brown, Jonathan Tabak, et al.
BMC Cancer|April 18, 2015
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcomeKaren Gambaro, Michael C J Quinn, Katia Y Cáceres-Gorriti, et al.
Orphanet Journal of Rare Diseases|February 26, 2013
Small cell ovarian carcinoma: genomic stability and responsiveness to therapeuticsLisa F Gamwell, Karen Gambaro, Maria Merziotis, et al.
International Journal of Molecular Sciences|January 11, 2024
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line TherapyKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 28, 2023
Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in CanadaKaren Gambaro, Mélanie Groleau, Suzan McNamara, et al.
Cancers|December 7, 2019
Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic DataBernhard Blank-Landeshammer, Vincent R Richard, Georgia Mitsa, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Bulletin De L'Academie Nationale De Medecine|October 26, 2005
[Embryonic stem cells and epidermal commitment]Daniel Aberdam, Karen Gambaro, Robert Barthel, et al.
Cell Cycle (Georgetown, Tex.)|February 1, 2007
Key role of p63 in BMP-4-induced epidermal commitment of embryonic stem cellsDaniel Aberdam, Karen Gambaro, Philippe Rostagno, et al.
Plos One|October 18, 2008
DeltaNp63 is essential for epidermal commitment of embryonic stem cellsAlain Medawar, Thierry Virolle, Philippe Rostagno, et al.
Comptes Rendus Biologies|July 17, 2007
Embryonic stem cells as a cellular model for neuroectodermal commitment and skin formationDaniel Aberdam, Karen Gambaro, Alain Medawar, et al.
Surgery|August 6, 2019
Multiplexed real-time polymerase chain reaction cell-free DNA assay as a potential method to monitor stage IV colorectal cancerSudhir Sinha, Hiromi Brown, Jonathan Tabak, et al.
BMC Cancer|April 18, 2015
Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcomeKaren Gambaro, Michael C J Quinn, Katia Y Cáceres-Gorriti, et al.
Orphanet Journal of Rare Diseases|February 26, 2013
Small cell ovarian carcinoma: genomic stability and responsiveness to therapeuticsLisa F Gamwell, Karen Gambaro, Maria Merziotis, et al.
International Journal of Molecular Sciences|January 11, 2024
A Phase II Exploratory Study to Identify Biomarkers Predictive of Clinical Response to Regorafenib in Patients with Metastatic Colorectal Cancer Who Have Failed First-Line TherapyKaren Gambaro, Maud Marques, Suzan McNamara, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|December 28, 2023
Third-line treatment patterns in HER2-positive metastatic breast cancer: a retrospective analysis of real-world data in CanadaKaren Gambaro, Mélanie Groleau, Suzan McNamara, et al.
Cancers|December 7, 2019
Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic DataBernhard Blank-Landeshammer, Vincent R Richard, Georgia Mitsa, et al.
Pageof 2